Grants-in-Aid

Commencing in 2020, all applications for Cancer Council Victoria Grants-in-Aid will apply directly to Cancer Council Victoria. Applications will open in June 2020. More information will be available over the coming months. 

For researchers applying to NHMRC Ideas Grants in 2020, the application process is outlined here.

Victorian researchers remain eligible for Cancer Council NSW Project Grant scheme funding (previously Box Rallies). For information about how to apply for Cancer Council NSW Project Grant scheme funding click here.

Grants-in-Aid support research for 1 to 3 years. They're awarded based on each project's:

  • relevance to cancer,
  • excellence,
  • the value of the research, and
  • the researcher's capacity to successfully complete the research described in the application.

All applications go through a rigorous peer-review process. In 2019 Cancer Council Victoria spent $4 million on Grants-in-Aid, including funding for low survival cancers research from the Victorian Government through the Victorian Cancer Agency and ovarian cancer research from the Ovarian Cancer Research Foundation. Current recipients are listed below.


New projects commencing in 2020

Dr Holly Barker, Dr Kristy Shield-Artin, Dr Cassandra Vandenberg and Dr Gayanie Ratnayake 
The Walter and Eliza Hall Institute of Medical Research
Identifying new treatment options for the rare and aggressive ovarian carcinosarcoma (2020 -2022)
Co-funded by the Ovarian Cancer Research Foundation 

Dr Paul Beavis, Prof Phillip Darcy, Prof Benjamin Solomon and Prof Sherene Loi
Peter MacCallum Cancer Centre
Enhancing cell-based therapy of cancer (2020 -2022)

A/Prof Daniel Buchanan, Prof Mark Jenkins, Prof Ingrid Winship, Prof Finlay Macrae, Prof Alex Boussioutas and A/Prof Christophe Rosty
University of Melbourne
Why does colonoscopy fail to prevent cancer of the large bowel in people with Lynch syndrome? (2020 -2022)

Prof Suzanne Cory and Dr Gemma Kelly
The Walter and Eliza Hall institute of Medical Research
Testing a promising new therapeutic target (MNT) to improve treatment of diverse human lymphomas and other cancers driven by high levels of the oncoprotein MYC (2020 -2022)

Prof Paul Donnelly and A/Prof Carleen Cullinane
University of Melbourne
Diagnostic imaging and therapy of cancers with copper radiopharmaceuticals (2020 -2022)

Dr Debra Gook, A/Prof David Westerman and Prof Claus Anderson
The Royal Women’s Hospital
Purging cancer cells from ovarian tissue cryo-stored from women with leukemia for safe autotransplantation and restoration of fertility (2020 -2022)

Dr Ian Majewski and Dr Peter Valk
The Walter and Eliza Hall Institute of Medical Research
How does the DNA damage that accumulates with age influence cancer risk? (2020 -2022)

Dr Delphine Merino, Dr Melissa Davis and Dr Belinda Yeo
Olivia Newton-John Cancer Research Institute
Design new treatments for patients with aggressive breast cancer using sequencing and drug response prediction (2020 -2022)

Dr Ashley Ng, Dr Kira Behrens, Prof Warren Alexander,  Dr Rebecca Feltham, Prof John Silke and Dr David Komander
The Walter and Eliza Hall Institute of Medical Research
Drugging Undruggable Targets in Ph+ B-cell Acute Lymphoblastic Leukaemia (2020 -2022)

Prof Richard Pearson
University of Melbourne
Combinatorial targeting of cellular “housekeeping” processes to treat cancer (2020 -2022)

Prof Andrew Perkins
Monash University
Towards a cure for myelofibrosis  (2020 -2022)
Funded by the Victorian Government through the Victorian Cancer Agency 

A/Prof Jake Shortt and Dr Lev Kats
Monash University
Determining the reasons why leukaemia and lymphoma become resistant to treatments that alter
the methylation of cancer DNA (2020 -2022)

Dr Lorey Smith and Dr Brendon Monahan
Peter MacCallum Cancer Centre
Preventing Resistance to Targeted Therapy in Melanoma (2020 -2022)

Dr Florian Wiede
Peter MacCallum Cancer Centre
Enhancing the immune system in combating liver cancer in obesity (2020 -2022)
Funded by the Victorian Government through the Victorian Cancer Agency 

Projects commenced in 2019

Prof Robin Anderson, Prof Robert Parton
Olivia Newton-John Cancer Research Institute
Loss of a protein called caveolin-1 in host cells surrounding tumour results in promotion of breast cancer metastasis (2019-2021)

 

Dr Nicholas Clemons, Prof Wayne Phillips, Dr Gang Chen, Dr Cuong Duong, A/Prof Sarah-Jane Dawson, Prof David Watson, Prof Reginald Lord, A/Prof David Wang
The University of Melbourne
Development of a simple blood test to guide treatment decisions for patients with oesophageal cancer (2019-2021)
Funded by the Victorian Government through the Victorian Cancer Agency 
 
Dr James Dowty, A/Prof Daniel Buchanan, Prof Ingrid Winship, A/Prof Robert Waterland, Dr Jihoon Joo, Prof Mark Jenkins, Prof Melissa Southey
The University of Melbourne
Heritable methylation marks associated with colorectal cancer risk (2019-2020)

 

Dr Moritz Eissmann, Prof Matthias Ernst, Prof Alex Boussioutas
La Trobe University
Testing antibodies inhibiting IL33-signalling against gastric cancer (2019-2021)
Funded by the Victorian Government through the Victorian Cancer Agency 

 

A/Prof Thomas Gebhardt
The University of Melbourne
Long-term immune control of clinically invisible melanoma (2019-2021)
 
Dr Catherine Granger
The University of Melbourne
A randomised control trial to evaluate the effect of exercise and self-management on outcomes of people with operable lung cancer (2019-2021)
Funded by the Victorian Government through the Victorian Cancer Agency 
 
Dr Lev Kats, Prof Ricky Johnstone
Peter MacCallum Cancer Centre
Development of new targeted therapies for acute myeloid leukaemia (2019-2021)
 
Dr Simon Keam
Peter MacCallum Cancer Centre
Understanding and avoiding radiation resistance in prostate cancer using personalised medicine (2019-2021)
 
Prof John Mariadason
Olivia Newton-John Cancer Research Institute
A new way to treat bowel cancer (2019-2021)
 
Prof Neil O'Brien-Simpson, A/Prof Andrea O'Connor, Prof Michael McCullough, Dr Jason Lenzo
The University of Melbourne
Under the tongue vaccine for oral and oesophageal cancers (2019-2021)
 
Dr Lorraine O'Reilly, Prof Andreas Strasser, A/Prof Nicholas Huntington
The Walter and Eliza Hall Institute of Medical Research
Combating immunotherapy toxicities to guide safer gastric cancer therapy using a new pre-clinical model (2019-2021)
 
A/Prof Louise Purton, A/Prof Carl Walkley, Dr Meaghan Wall, Dr Helene Jousset
St Vincent's Institute of Medical Research
Identifying better therapies for blood cell cancers (2019-2021)
 
Prof Andrew Scott, A/Prof Hui Gan, Prof Weisan Chen
Olivia Newton-John Cancer Research Institute
Improving GBM Response to Antibody-Drug Conjugate Therapy (2019-2020)
 
Prof Matthew J. Watt, Dr Renea A. Taylor, A/Prof Daniel Nomura
The University of Melbourne
Targeting fatty acid metabolism for prostate cancer therapy (2019-2021)

Projects commenced in 2018 

Dr Ashwini Chand, Prof Matthias Ernst, Prof Michael Parker
La Trobe University
Repurposing drugs for the treatment of gastrointestinal cancers (2018-2020)

 

A/Prof Phillip Darcy, Dr Paul Beavis, Prof Dale Godfrey
Peter MacCallum Cancer Centre
Investigating the role of a novel immune cell subset in cancer (2018-2020)

 

Dr Daniel Gough, Prof David Watkins, Dr Kate Sutherland, A/Prof Jake Shortt
Hudson Institute of Medical Research
Identifying new treatments for platinum resistant Small Cell Lung Cancer (2018-2020) 

 

A/Prof Daniel Gray, Prof David Huang, Prof Andrew Roberts, Prof Terence Speed
The Walter and Eliza Hall Institute of Medical Research
Understanding how new therapies target blood cancer (2018-2020)

 

A/Prof Craig Harrison, Dr Paul Gregorevic, A/Prof Jose Garcia
Monash University
Towards precision medicine for cancer cachexia (2018-2020)

 

A/Prof Christine Hawkins, Prof Andrew Scott, A/Prof Carl Walkley
La Trobe University
Testing new drugs for bone cancer (2018-2020)

 

A/Prof Thomas John, Prof Andrew Scott, A/Prof Hui Gan
The Olivia Newton-John Cancer Research Institute
New treatments for mesothelioma (2018-2020)

 

Prof Ricky Johnstone, A/Prof Jake Shortt
Peter MacCallum Cancer Centre
Targeting transcriptional addiction for cancer therapy (2018-2020)

 

Dr Gemma Kelly, Dr Marco Herold, Dr MaryAnn Anderson
The Walter and Eliza Hall Institute of Medical Research
Investigating a novel anti-cancer agent targeting MCL-1 for the treatment of haematological cancers (2018-2020)

 

Prof Christina Mitchell, Prof Catriona McLean
Monash University
Regulation of phosphoinositide 3-phosphate tumour suppressor activity (2018-2020)

 

Dr Donia Moujalled
Monash University
New treatments for Acute lymphoblastic leukaemia (2018-2020)

 

Prof David Ritchie, Dr Nicholas Huntington
The University of Melbourne
Inhibiting immune cell function to improve stem cell transplant outcomes in leukaemia (2018-2020)

 

Prof Tony Tiganis, Prof Catriona McLean
Monash University
Determining how liver cancer develops in obesity (2018-2020)

Projects commenced in 2017 

Dr Urmi Dhagat, Dr Sophie Broughton, Prof Michael Parker, A/Prof Louise Purton
The University of Melbourne (2018-2019); St Vincent's Institute of Medical Research (2017-2018)
How does the protein hormone interleukin-3 regulate cell signalling in leukaemic cells? (2017-2019) 

 

A/Prof Hui Gan, Prof Andrew Scott, Prof John Mariadason, A/Prof Elgene Lim, Prof Niall Tebbutt
La Trobe University
Anti-EGFR drug conjugates for the treatment of colorectal and breast cancer  (2017-2019) 

 

Prof Suzanne Garland, Prof Sepehr Tabrizi, A/Prof Richard Hillman, Dr Alyssa Cornall, Dr Fengyi Jin, Dr Jennifer Roberts, Dr Isobel Poynten, Dr Monica Molano, Dr Dorothy Machalek
The University of Melbourne
Assessment of potential tests for anal cancer screening (2017-2019)

 

Prof John Hopper, Dr Daniel Schmidt, Dr Enes Makalic, Dr Carmel Apicella, Dr Louise Keogh, Dr Helen Frazer, Dr Pierre-Antoine Dugue, Dr Ralph Highnam, Mr Kevin Nguyen, Dr Jill Evans
The University of Melbourne
Automated measures that predict risk and masking of breast cancer  (2017-2019)

 

Dr Peter Janes, Prof Andrew Scott, A/Prof Thomas John
Monash University (2017-2018); La Trobe University (2018-2019)
Targeted antibody therapy for malignant mesothelioma 
Lyall Watts Mesothelioma Research Grant (2017-2019)

 

Dr Ian Majewski, Prof David Huang, Prof Andrew Roberts
The Walter and Eliza Hall Institute of Medical Research
Targeting cell survival pathways to treat cancer (2017-2019) 

 

Dr Kate Murphy, Prof John Silke, Prof Gordon Lynch, Prof Leanne Delbridge
The University of Melbourne
A novel treatment for heart failure in cancer and with chemotherapy (2017-2019)

 

Dr Lan Nguyen
Monash University
Elucidating the dual functions of YAP in breast cancer (2017-2019) 

 

Dr Belinda Parker, A/Prof Phil Darcy
La Trobe University
Predicting the benefit of therapies for patients with triple negative breast cancer (2017-2019)

 

A/Prof Helena Richardson, A/Prof Patrick Humbert, Prof Josef Penninger
La Trobe University
Determining how a novel protein controls cell shape and cancer progression  (2017-2019)

 

Dr Adam Uldrich, Dr Daniel Pellicci, Dr Ilia Voskoboinik
The University of Melbourne
Examining the anti-cancer properties of gamma delta T cells (2017-2019) 
A/Prof Carl Walkley, A/Prof Wallace Langdon, Dr Meaghan Wall, Dr Alistair Chalk
St Vincent's Institute of Medical Research
Understanding how blood cancers form (2017-2019) 

Projects commenced in 2016 

A/Prof Kieran Harvey, Dr Nicola Waddell, A/Prof Kaylene Simpson
Peter MacCallum Cancer Centre
What causes mesothelioma and how can we treat it?
Lyall Watts Mesothelioma Research Grant (Sept 2016 - Aug 2019)

 

Dr Nicole Haynes, Prof Ricky Johnstone, A/Prof Sherene Loi
The University of Melbourne (Peter MacCallum Cancer Centre)
Targeting HER2+ breast cancer with novel combination therapies (2016-2018)

 

Dr Peter Janes, Prof Dimitar Nikolov, Dr Elgene Lim
Monash University
Novel therapeutic antibodies to fight drug resistant breast cancers  (2016-2018)

 

Prof Stephen Nutt, A/Prof Lynn Corcoran
The Walter and Eliza Hall Institute of Medical Research
Exploring new molecular targets on plasma cells as therapies for multiple myeloma  (2016-2018)

 

Dr Gretchen Poortinga, Prof Grant McArthur, Prof Ross Hannan
Peter MacCallum Cancer Centre
Understanding how cancer cells become resistant to a novel treatment of blood cancers (2016-2018) 

 

A/Prof Louise Purton, Dr Meaghan Wall, Dr Carl Walkley
St Vincent's Institute of Medical Research
Identifying better treatments for blood cell cancers (2016-2018)

 

Prof Jamie Rossjohn, Prof Andrew Brooks
Monash University
Exploring how tumour cells are recognised by Natural Killer cells (2016-2018)

 

Dr Karen Sheppard, Prof Grant McArthur
Peter MacCallum Cancer Centre
Understanding why melanomas stop responding to therapy that inhibits cells from growing  (2016-2018)

 

Prof Andreas Strasser, Dr Daniel Gray
The Walter and Eliza Hall Institute of Medical Research
How does competition between cells impact tumour development (2016-2018)

 

Prof Jose Villadangos, Prof William Heath
The University of Melbourne
Improving cancer killing with live cell therapy (2016-2018)

 

Dr Florian Wiede
Monash University (2016-2017); The University of Melbourne (2018)
Defining a novel immunotherapy for more effective cancer treatment (2016-2018)